Related content

Circulating levels of vascular endothelial growth factor (VEGF), matrix metalloproteinase-3 (MMP-3), and BCL-2 in malignant melanoma

By Tas Faruk   Duranyildiz Derya   Oguz Hilal   Camlica Hakan   Yasasever Vildan   Topuz Erkan  

Medical Oncology, Vol. 25, Iss. 4, 2008-12 ,pp. : 431-436

Humana Press, Inc

Access to resources Recommend Favorite

Determination of vascular endothelial growth factor (VEGF) overexpression in soft tissue sarcomas and the role of overexpression in leiomyosarcoma

By Potti Anil   Ganti Apar   Tendulkar Ketki   Sholes Kaley   Chitajallu Sidharth   Koch Michael   Kargas Steven  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 1, 2004-01 ,pp. : 52-56

Springer Publishing Company

Access to resources Recommend Favorite

Overexpression of c-erbB-2 is related to a higher expression of vascular endothelial growth factor (VEGF) and constitutes an independent prognostic factor in primary node-positive breast cancer after adjuvant systemic treatment

By Linderholm B.   Andersson J.   Lindh B.   Beckman L.   Erlanson M.   Edin K.   Tavelin B.   Grankvist K.   Henriksson R.  

European Journal of Cancer, Vol. 40, Iss. 1, 2004-01 ,pp. : 33-42

Elsevier

Access to resources Recommend Favorite

Co-expression of vascular endothelial growth factor C (VEGF-C) and c-erbB2 in human breast carcinoma

By Hoar F.J.   Chaudhri S.   Wadley M.S.   Stonelake P.S.  

European Journal of Cancer, Vol. 39, Iss. 12, 2003-08 ,pp. : 1698-1703

Elsevier

Access to resources Recommend Favorite

Correlation and expression of p53, HER-2, vascular endothelial growth factor (VEGF), and e-cadherin in a high-risk breast-cancer population

By Howard Eugene M.   Lau Stephen K.   Lyles Robert H.   Birdsong George G.   Tadros Talaat S.   Umbreit Jay N.   Kochhar Ruby  

International Journal of Clinical Oncology, Vol. 9, Iss. 3, 2004-06 ,pp. : 154-160

Springer Publishing Company

Access to resources Recommend Favorite